GetTopicDetailResponse(id=b615e5789b6, topicName=第三次批準(zhǔn), introduction=第三次批準(zhǔn), content=null, image=null, comments=1, allHits=561, url=https://h5.medsci.cn/topic?id=75789, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=97382, tagList=[TagDto(tagId=97382, tagName=第三次批準(zhǔn))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1803708, encodeId=eddf1803e0811, content=<a href='/topic/show?id=b615e5789b6' target=_blank style='color:#2F92EE;'>#第三次批準(zhǔn)#</a>, objectTitle=默克的PD-1單抗Keytruda獲得國內(nèi)非小細(xì)胞肺癌適應(yīng)癥的第三次批準(zhǔn), objectType=article, longId=184025, objectId=7f2c18402514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f2c18402514, replyNumber=0, likeNumber=96, createdTime=2020-09-13, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f2c18402514, moduleTitle=默克的PD-1單抗Keytruda獲得國內(nèi)非小細(xì)胞肺癌適應(yīng)癥的第三次批準(zhǔn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7f2c18402514)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
